Authors: RIZVI NA MARSHALL JL NESS E YEO J GILL GM TRUGLIA JA LOEWEN GR JAUNAKAIS D ULM EH HAWKINS MJ

Citation: Na. Rizvi et al., PHASE-I STUDY OF 9-CIS-RETINOIC ACID (ALRT1057 CAPSULES) IN ADULTS WITH ADVANCED CANCER, Clinical cancer research, 4(6), 1998, pp. 1437-1442

Authors: DZERK AM CARLSON A LOEWEN GR SHIRLEY MA LEE JW

Citation: Am. Dzerk et al., A HPLC METHOD FOR THE DETERMINATION OF 9-CIS RETINOIC ACID (ALRT1057)AND ITS 4-OXO METABOLITE IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 16(6), 1998, pp. 1013-1019

Authors: MILLER VA BENEDETTI FM RIGAS JR VERRET AL PFISTER DG STRAUS D KRIS MG CRISP M HEYMAN R LOEWEN GR TRUGLIA JA WARRELL RP

Citation: Va. Miller et al., INITIAL CLINICAL-TRIAL OF A SELECTIVE RETINOID-X RECEPTOR-LIGAND, LGD1069, Journal of clinical oncology, 15(2), 1997, pp. 790-795

Authors: MILLER VA RIGAS JR BENEDETTI FM VERRET AL TONG WP KRIS MG GILL GM LOEWEN GR TRUGLIA JA ULM EH WARRELL RP

Citation: Va. Miller et al., INITIAL CLINICAL-TRIAL OF THE RETINOID RECEPTOR PAN AGONIST 9-CIS RETINOIC ACID, Clinical cancer research, 2(3), 1996, pp. 471-475

Authors: HERMAN RJ LOEWEN GR ANTOSH DM TAILLON MR HUSSEIN S VERBEECK RK

Citation: Rj. Herman et al., ANALYSIS OF POLYMORPHIC VARIATION IN DRUG-METABOLISM .3. GLUCURONIDATION AND SULFATION OF DIFLUNISAL IN MAN, Clinical and investigative medicine, 17(4), 1994, pp. 297-307